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1.    INTRODUCTION
Quality-of-life  assessment  as  part  of  a  multimodal  outcome-assessment  is  being 
increasingly  measured  in  clinical  and  health  services  research.  This  is  especially 
important  in  chronic  degenerative  conditions  like  cervical  spondylotic  myelopathy 
(CSM) which rarely is fatal, nor is completely cured, and hence has no clear endpoints 
for outcome assessment (22). 
In diseases such as CSM, outcomes have been historically measured using myelopathy 
scales like those by Nurick, Harsh, Cooper and the JOA score. Although disease-specific 
scales like these are used to describe both, disease severity, and outcomes of treatment, 
they do not incorporate factors that may contribute to quality of life outcomes. It has been 
noted in a previous study that patients with CSM have deficiencies that extend beyond 
motor, sensory and bladder dysfunction, into the realms of emotional and mental health 
(15).  These  can  only  be  assessed  by  using  generic  outcome-measurement  QOL 
instruments  like  the  SF-36  (Medical  Outcomes  Study  Short  Form-36)  and  the 
WHOQOL-BREF. Although both are generic QOL instruments, they measure different 
constructs (11). While the SF-36 measures objective health-related QOL, the WHOQOL-
BREF measures subjective global QOL.
This study uses WHOQOL-BREF for the first time for patients with CSM along with the 
commonly used SF-36 generic instrument, to assess functional outcome across different 
Nurick grade patients. 
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2.   OBJECTIVES
1) To assess the quality of life (QOL) preoperatively and at follow-up in patients 
with cervical spondylotic myelopathy (CSM) undergoing un-instrumented central 
corpectomy (CC).
2)  To determine the relationships between Nurick grade, SF-36, WHOQOL-BREF 
and patient perceived outcome in these patients.
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 3.    REVIEW OF   LITERATURE  
3.1 Cervical Spondylotic Myelopathy  
Cervical spondylotic myelopathy (CSM) is a chronic degenerative condition of the 
cervical spine that results in narrowing of the spinal canal and disruption of spinal cord 
function (3). This disease was first characterised by Brain et al in 1952. Since then, 
researchers have gathered substantial experimental and clinical evidence on its etiology 
and pathophysiology. It is commonly accepted that a combination of compressive forces 
both, anatomical and dynamic, as well as vascular phenomena are responsible for this 
clinical syndrome (12). Its clinical manifestations and natural history are known to be 
variable and unpredictable, with some patients having a mild protracted course, and 
others progressive disability (21). Symptoms of CSM range from neck pain, walking 
difficulties, sphincter dysfunction, impotence and numb clumsy hands (23, 30, 31). 
Treatment  options  for  CSM  include  physical  therapy,  neck  brace  therapy,  expectant 
management  and surgical  spinal  cord  decompression  with  or  without  fusion.  Several 
surgical strategies have been used in the past fifty years or so for the treatment of CSM, 
with proponents for either the anterior or posterior surgical approach. Of concern is the 
proposition that surgical treatment does not alter the natural history of patients with CSM 
(12). 
Because the impairments of patients with this protracted disease extend beyond motor, 
sensory and bladder  dysfunctions,  into  the  realms  of  emotional  and mental  health,  a 
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robust  evaluation  of  treatment  outcome  becomes  difficult.  Quality  of  life  (QOL) 
parameters have become viable considerations in this direction.
3.2 Quality of Life – the concept
Diseases can cause premature death resulting in decreased “quantity of life”, but more 
often they cause structural and functional limitations that may seriously affect the quality 
of life. Death is easy to identify and record and therefore mortality has been a standard 
method for quantifying the impact of diseases. 
Patient reported outcomes are measured in clinical and health services studies and are 
especially important for individuals with chronic conditions for whom the goal of health 
care is optimizing daily functioning and well-being, as well as extending longevity (11). 
The  whole  class  of  patient-reported  outcomes is  often  referred  to  as  Quality  of  Life 
(QOL),  a  term used  interchangeably  with  health  related  quality  of  life  (HRQL)  and 
subjective well being (SWB). Concepts that are generally measured in these areas include 
somatic  symptoms,  physical  capability,  psychological  issues,  social  activities  and 
cognitive functioning, and also broad concepts of life satisfaction.
QOL has been difficult to measure and therefore its use in healthcare settings has been 
comparatively  recent  (35).  QOL  assessment  does  not  replace  the  existing  outcome 
variables like mortality and morbidity measurements but it can be an additional outcome 
variable, giving information about a patient’s life, which other variables do not. 
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QOL assessments have mostly been used in the past in the area of malignancies although 
their use has become common of late in several other chronic conditions like CSM. 
Assessment of QOL provides measurement of functioning and well-being rather than of 
diseases and disorders, hence it is more comprehensive and compatible with the World 
Health  Organization’s  (WHO) concept  of  health.  It  focuses  attention on aspects  of  a 
patient’s life beyond symptoms and signs. It encompasses “Those attributes valued by 
patients including their resultant comfort or sense of well-being; the extent to which they 
were able to maintain reasonable physical, emotional and intellectual function; and the 
degree to  which  they retain  their  ability to  participate  in  valued  activities  within the 
family, in the workplace, and in the community” (29). 
 The WHO Quality of life assessment group has defined QOL as “Individuals’ perception 
of their position in life in the context of the culture and the value system in which they 
live and in relation to their goals, expectations, standards and concerns” (1).  
Despite  the influence of WHO quality of life  assessment  group’s  definition of QOL, 
operationalisation of QOL still varies across different methods and studies.
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3.3  Outcome-Assessment Methods for QOL
In diseases such as CSM where the primary effect is on patient morbidity,  there is a 
growing appreciation for the importance of measuring health related QOL as a means of 
understanding the impact of disease symptoms and treatments on patients’ lives. Health 
related  Quality  of  Life  (HRQL)  can  be  assessed  by  health  status  instruments  and 
preference-based techniques. 
Primary  dimensions  of  health-related  quality  of  life  (HRQL)  include:  physical 
functioning,  psychological  functioning,  social  functioning  and  role  activities,  and 
individuals’ overall life satisfaction and perceptions of their health status (21). Additional 
HRQL  dimensions  include  neuropsychological  functioning,  personal  productivity, 
intimacy and sexual functioning, sleep disturbance, pain, study-specific symptoms, and 
spirituality. 
Health  status  instruments  are  sub-divided  into:  generic  health  status  techniques  that 
encompass many aspects contributing to QOL, and disease-specific status techniques that 
focus on a particular disease or condition (17). Most commonly used generic health status 
instruments and what they focus on are listed for comparative purposes in Table 3-1 
below (4).
10
Instrument Domains/ Dimensions covered Number of 
items
European Quality of Life 
Instrument (EQ-5D)
Mobility
Self-care
Usual activities
Pain
Anxiety / depression
5
Medical Outcome Study 
Short Form 36 (SF-36)
Physical health
Mental health
Social functioning
Role limitations due to physical health
Role limitations due to emotional 
health 
General health
Vitality
 Bodily pain
36
Nottingham Health Profile 
(NHP)
Physical  mobility
Pain
Emotional Reaction
Energy level
Sleep
Social interaction
38
Quality of Life Index (QL-I) Activity
Daily living
Health
Support
Outlook
6
WHO Disability assessment 
Schedule (WHODASII)
Understanding and communication
Getting around
Self care
Getting along with people
Participation in society
36
WHOQOL-BREF Physical Health
Psychological health
Social relationships
Environment
26
Table 3-1. Common generic health status instruments and their domains
The most common generic health status instrument amongst those listed above is SF-36 
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(17),  while  the  cross-culturally  adaptable  concept  and  methodical  strengths  of 
WHOQOL-BREF suggest that the latter may also have a place among the leading generic 
QOL instruments (36). 
Disease-specific  health  status  measurements  techniques  include  instruments  like  the 
Nurick scale, Cooper scale, Harsh scale, and the Japanese Orthopedic Association (JOA) 
scale. These are designed to be sensitive to the manifestations of a particular disease and 
provide a single value for QOL. However these are applicable only to specific diseases or 
conditions. The Nurick scale is based mostly on ambulatory function while the Harsh, 
Cooper and the JOA scales include additional items such as sensation, upper extremity 
function,  and  sphincter  control.  These  scales  classify  patients  into  various  disease 
categories and are used to describe both CSM disease severity and the outcomes of CSM 
treatment (17). 
Preference based QOL measurement techniques also known as health value measures, 
elicit patients’ valuations for their current health state expressed on a single zero to one 
scale.  These instruments can be used for a variety of diseases. They integrate all domains 
contributing  to  QOL  to  the  extent  that  the  domains  are  important  to  each  patient. 
However, these instruments are resource intensive (requiring patient interviews) and may 
be difficult for some patients to complete. Responses may also be influenced by patients’ 
attitudes towards risk, time or money. Common instruments in this category include: like 
Visual Analogue Scale, Standard Gamble, Time trade-off, and Willingness to pay. While 
the Visual Analogue Scale asks patients to value their current health on a linear scale, the 
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Standard Gamble asks them to make a hypothetical choice between remaining in their 
current health state or accepting the result  of a gamble with a variable probability of 
either  death  or  perfect  health  as  the  outcome.  Time  Trade  off  was  developed  as  an 
alternative utility measurement that may be easier to administer than the standard gamble. 
It requires patients to make a hypothetical choice between living out their current state of 
health or accepting a shorter life span in perfect health. Both Standard Gamble and Time 
Trade off are used to measure disease severity and treatment outcomes. Another method 
for measuring health states is the Willingness-to-pay technique that provides a monetary 
valuation of state of health by determining how much patients would be willing to pay to 
improve their health (17).
 Preference  based  QOL measurements  are  becoming increasingly popular  due to  the 
advantages they offer in terms of incorporating individual attitudes towards functional 
status, pain, etc., and by way of their capability of being incorporated into cost effective 
analysis and decision making processes (27). Regardless of these advantages, however, 
these instruments have not been used widely for evaluation of QOL in spine disease, 
going by the marked dearth of literature related to this.  
Different diseases have been found to have a differential effect on functioning of patients 
in domains of QOL. Consequently, the contribution of specific domains to QOL may 
differ between diseases (1). 
Selection  of  appropriate approach and instrument for evaluating QOL should be based 
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on: clear definition of study endpoints,  preferred use of standardized, valid and reliable 
scales,  knowledge  of  strengths  and  weaknesses  of  various  instruments,  with  due 
consideration to the characteristics of the study population (24). For outcome measures to 
be of  any use,  they must  be responsive,  valid,  practical  and reliable.  Responsiveness 
refers  to  the  ability  to  detect  true  changes  in  health  beyond  the  expected  random 
variability, while validity is gauged by the extent to which a questionnaire measures what 
it  is  intended to  measure.  Questionnaires  should be  as  brief  as  possible  to  minimize 
response  burden (22).  Reliability  simply refers  to  the  stability  and reproducibility  of 
measures over time or across methods of gathering data. 
3.4   Nurick Grades
Nurick grading system categorises patients with  myelopathic grades as shown in Table 
3-2.
Nurick 
grade
Description
0 Signs or symptoms of root involvement but without evidence of spinal 
cord disease.
1 Signs of spinal cord disease but no difficulty in walking.
2 Slight difficulty in walking which did not prevent full-time employment.
3 Difficulty walking which prevented full-time employment or the ability 
to do all housework, but which was not severe as to require someone 
else’s help to walk.
4 Able to walk with someone else’s help or with the aid of a frame 
5 Chair-bound or bedridden.
Table 3-2 Nurick grades
These six grades (0 to 5) were initially developed by Nurick in 1972 in his study on the 
pathogenesis of cervical spondylotic myelopathy. The study patients were classified in 
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terms of the grade of disability based on degree on difficulty in walking recorded at the 
time of admission (31).
This  disease-specific  health  status  instrument  has  since been  used  very commonly in 
various studies. It provides ease of application, and a single value for QOL. 
  
3.5   Medical Outcomes Study Short-Form (SF-36)
Ware et al state that general health can be measured using the various techniques briefly 
described above, the most widely used being the SF-36 instrument which is a shortened 
version of a battery of 149 status questions developed and tested on a population of over 
twenty two thousand patients (39). This exercise was a part of the Medical Outcomes 
study, which was an attempt to analyze how specific parts of the American health care 
system affect the outcomes of care. 
 The SF-36 was developed to assess functioning status and well-being in a US population 
of 2474 patients with a wide range of conditions. Eleven questions were selected in this 
version  while  retaining  the  validity  and  reliability  of  the  parent  questionnaire. 
Subsequently  SF-36  has  been  validated  in  Chinese,  Cuban,  Spanish,  Dutch,  French, 
Greek, Italian, Japanese, and Swedish speaking populations. It has also been validated in 
patients  with  numerous  diseases  including  benign  prostatic  hypertrophy,  cancer, 
congestive heart failure, coronary artery disease, diabetes Type II, hypertension, low back 
pain, recent myocardial infarction, sciatica, and stroke (18). 
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 A study by King et al has evaluated the construct validity and reliability of the SF-36 
health status instrument in relationship with Nurick, Cooper, Harsh and modified JOA 
scales and demonstrated that SF-36 provides reliable and valid data in CSM patients also 
(18).  
SF-36  yields  a  profile  of  functional  health  and  well-being  scores  as  well  as 
psychometrically- based physical and mental health summary measures.  It is comprised 
of eight separate multi-item scales (mentioned above) that contain 2 to 10 items each and 
a single item to assess health transition. A sub-scale score is calculated for each of the 8 
dimensions.  In  recent  years  a  scoring  algorithm  has  been  developed  to  calculate  a 
Physical Component summary (PCS) and the Mental Component summary (MCS). The 
physical  functioning,  role  limitations  due  to  physical  health,  bodily  pain  and general 
health sub-scales are integrated to form the PCS; and the vitality, social functioning, role 
limitations due to emotional  health, and mental health sub-scales are combined to form 
the MCS (see Figure 3-1).  Summary measures such as these are useful in reducing the 
number  of  separate  outcomes  to  be  assessed  during  a  particular  study,  which  can 
complicate data analysis, while still preserving the ability of the instrument to examine 
two major aspects of daily life- physical and mental health dimensions (29). 
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Fig. 3-1   SF-36 Scales Measure Physical and Mental Components of Health (38)
3.6    WHOQOL-BREF                                                           
In consonance with its definition of Quality of Life, the WHOQOL Group takes the view 
that it is important to know how satisfied, or otherwise, people are by important aspects 
of  their  life,  and  that  this  interpretation  will  be a  very individual  matter.  The  WHO 
Quality of life assessment - the WHOQOL 100- is a cross culturally valid assessment of 
well  being.  It  was developed through collaborative studies in  15 sites throughout the 
world  all  working  in  their  local  languages.  Agreed  common  protocols  were  used 
simultaneously by all centers in each stage of the development process (36). The original 
WHOQOL-100 was based on a 6 domain structure – physical, psychological, level of 
independence, social, environment and personal beliefs/ spirituality.
  Physical 
Component
General 
Health 
    Mental 
Component
Physical 
Function
Role  
Physical  
Bodily 
Pain
Mental
Health
Role  
Emotional 
 
Social 
Function
Vitality  
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The WHOQOL-BREF is an abbreviated version of WHOQOL-100 and is suited for use 
in situations where time is a constraint and where respondent burden (of completing the 
questionnaire) must be  minimal or where facet detail is unnecessary. WHOQOL-BREF 
has been developed on the basis of four domains - physical, psychological, social and 
environmental  health.   The WHOQOL-BREF contains  one item from each of the 24 
facets of quality of life included in the original version, plus two benchmark items from 
the original facet on overall QOL and general health- not included in scoring.  Although 
longer than some other short-forms, the WHOQOL-BREF covers a very broad range of 
facets that were agreed by international consensus. A noteworthy feature is the inclusion 
of social and environment domains for assessment.  It has wide ranging uses in clinical 
settings  and clinical  trials  (36).  The  four  domains  and their  related  facets  are  shown 
below in Figure 3-2.
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Physical 
-Domain 1
Pain
Energy
Sleep
Mobility
Activities
Medication 
Work
Social relations- 
Domain 3
+ve feelings
Cognitions
Self  esteem
Fig. 3-2. WHOQOL-BREF:  4-domain confirmatory factor model.
Spirituality
-ve feelings
Body image
Safety & 
Home environ’t
Finance
Health/social care
Information
Leisure
Physical Environ’t
Transport
   QOL
Personal 
Social support
Sex
Environment
-Domain 4
Psychological- 
Domain 2
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 The WHOQOL-BREF arises from 10 years of development research on QOL and health 
care.  It  is  a  person-centred,  multilingual  instrument  for  subjective  assessment  and  is 
designed for generic  use as a multi-dimensional  profile,  so enabling a wide range of 
diseases and conditions to be compared.  It consists of QOL items that are concerned with 
the  meaning  of  different  aspects  of  life  of  the  respondents  and  how  satisfactory  or 
problematic is their experience of them.  
 
Evidence of test-retest reliability of WHOQOL-BREF has already been established by 
the WHOQOL Group (41). Furthermore, Skevington et al have found that analysis of 
internal consistency, item-total correlations, discriminant validity and construct validity 
of their study data indicate that WHOQOL-BREF has good to excellent psychometric 
properties of reliability and performs well in preliminary studies of validity (36). 
The WHOQOL-BREF has several strengths. It is based on a cross-culturally sensitive 
concept and is available in most of the world’s major languages; hence it is appropriate 
for use in multinational collaborative research.  
 Thus, WHOQOL-BREF is  a sound and cross-culturally valid assessment of QOL as 
reflected its four domains and can be used in studies which incorporate QOL as one of 
several variables.  
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3.7   SF-36 and WHOQOL-BREF—A Comparison
                                             
Each instrument has its unique constructs and advantages. As indicated in literature, the 
SF-36 was originally developed as a generic instrument for health surveys. Subsequently 
it was widely used in studies of health-related Quality of Life. Therefore the items in 
SF-36 reflect more toward the scope of health status. The aim of WHOQOL-BREF, on 
the other hand, was to capture a broad ranging concept of QOL that even includes a 
domain on environment in its scope. 
There are several ways to compare QOL instruments. Spilker’s hierarchical QOL model 
consisting of a three-level pyramid that includes overall QOL, separate domains of QOL, 
and specific aspects of each domain (1) provides a useful methodology.  
 
According to Spilker, the overall QOL is defined as “an individual’s overall satisfaction 
with life, and one’s general sense of personal well-being”; this covers the first level of 
Spilker’s model. This can be interpreted as a global impression of overall QOL, measured 
by instruments like WHOQOL-BREF. The separate domains of QOL form the second 
level,  with  the  most  common  domains  being  psychological,  social  and  physical 
functioning. The third level of Spilker’s model consists of the specific components of 
each domain of QOL (37). This model provides an analytical framework for comparing 
instruments because it allows researchers to examine QOL elements at the same level and 
across different levels.
Another study conducted on HIV patients by Ping-Chuan Hsiung et al (10), indicated that 
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patients  with  fewer  symptoms  and  with  less  intensity  of  symptoms  had  significantly 
higher  scores on all  four domains  of  WHOQOL-BREF, eight  scales,  PCS,  and MCS 
(mental component summary) of the SF-36 scale. The correlations between the physical, 
psychological,  and  social  domains  of  the  WHOQOL-BREF  and  PF  (physical 
functioning), MH (mental health), and SF (social functioning) of the SF-36 were 0.51, 
0.75, and 0.54, respectively. There was also good correlation between PCS of the SF-36 
and the physical domain of the WHOQOL-BREF (r = 0.48), and between MCS and all 
four domains of the WHOQOL-BREF (r = 0.60–0.75).   They concluded that both SF-36 
and WHOQOL-BREF are valid and reliable for assessing QOL, and that in general, there 
are good correlations between the corresponding scales of the two instruments.  
A  study  conducted  by  Chan  Huang  et  al  (11),  suggests  that  the  SF-36’s  Physical 
Component summary (PCS) and the Mental Component summary (MCS) were weakly 
associated with WHOQOL-BREF (Figure 3-3). It suggests that SF-36 and WHOQOL-
BREF  measure  different  constructs:  the  SF-36  measures  health-related  QOL,  while 
WHOQOL-BREF measures global QOL.  
SF-36 is classified as the measure of an individual’s  internal capability of life,  while 
WHOQOL is known as a measure of inner life satisfaction or subjective enjoyment of life 
11).
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3.8   CSM and Outcome Measurement Studies
    PCS  Physical
    QOL
   Social
    QOL
Psychological
      QOL    MCS
Environment
      QOL
Fig. 3-3.   Relationships observed between domains of SF-36 and WHOQOL-BREF (18). 
0.04
0.15
0.09
0.14
0.11
     0.21
  0.33
0.07
0.30
0.35
0.36
0.54
0.48
   (Figures reflect the regression coefficients as observed in a study by Huang et al.)
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 Several authors have reported their studies of surgery in patients with CSM and reflected 
different results: 
 In  a  prospective  study  by  Lunsford  et  al  on  32  patients  assessed  1-7  years 
postoperatively, 50% patients were reported to have improved, and 50% were the same or 
had continued to deteriorate (11). 
In  a  10-year  study  by  Phillips  on  102  cases,  favorable  outcome  with  sustained 
improvement was reported in 67% of the patients (32).
Ebersold had retrospectively followed up 84 patients for a mean of 7 years and reported 
improvement in 70% patients following surgical decompression ( 7). 
 In a prospective, non-randomized study during a 10-year period on 51 patients submitted 
to  median  corpectomy and  fusion,  Marcondes  et  al  assessed  functional  outcomes  in 
addition  to  anatomical  and  neurological  results  (26).  Analysis  of  the  retrospectively 
collected assessment of the level of satisfaction showed that 80.6% of the patients were 
very satisfied or satisfied with the outcome and would decide again for the surgery (87%) 
if the results were previously known.
In a prospective study by King et al, the results of surgery in 62 patients were assessed 
over  a  6-month  follow-up  period  using  three  types  of  outcome  instruments  (16).  28 
patients  underwent  surgery.  There  were  no  base-line  differences  in  demographics, 
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symptoms, myelopathy scores, health status or values (based on generic and preference-
based outcome measures) between this group and the non-surgery-treated patients. At the 
six  month  follow-up  interval,  the  surgical  and  non-surgical  groups  were  essentially 
unchanged in terms of myelopathy scores,  heath status and values,  and there was no 
benefit from surgery. Patients’ postoperative perception of changes in their condition was 
not supported by the other outcome measures. In patients who reported improvement, 
only the SF-36 scores for mental health (MCS) had improved postoperatively. 
In the only prospective randomized trial to date of surgery for CSM, Kadanka et al (13) 
classified randomized patients into a surgical group and a conservative regimen group. 
Their  outcome measures  included a  modified  JOA scale,  timed 10 meter  walk,  self-
assessment  and blinded assessment  of a videotape of  activities  of  daily living.  Three 
years after randomization, the surgical group had fared no better than the conservative 
treatment group. 
3.9   SF-36 and CSM
King et al tested the validity (the extent to which a test measures what it is intended to 
measure) and reliability (the stability and reproducibility of measures of the same concept 
over time or across methods of collecting data) of the SF-36 in patients with CSM (18). 
The instrument was administered to a cohort of 88 patients on an outpatient basis. Such 
patients were found to exhibit decreased quality of life in all health domains, extending 
into the realms of emotional and mental  health.   The study suggested that the SF-36 
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measures a much broader range of health concepts than the disease-specific myelopathy 
scales which are focused predominantly on motor function. Analyses demonstrated that 
the SF-36 is a valid and reliable outcome instrument in patients with CSM.
Latimer et-al used the SF-36 to measure outcome in a cohort of 70 patients undergoing 
surgery  for  CSM  (22).   Health  status  was  measured  preoperatively  and  3  months 
postoperatively.  Twelve-month  follow-up  was  available  for  42  patients  in  the  study 
group. The study patients were found to have lower preoperative scores than age-matched 
population controls. Improvement in the scores (postoperative versus preoperative) was 
not defined in terms of an absolute value, but in terms of statistical significance (p<0.05). 
Comparing pre and postoperative SF-36 scores for the physical functioning domain, 64% 
of patients were found to have improved, 23% showed no change and 14% continued to 
deteriorate. These changes were similar to those in other domains and the other outcome 
measures. It was concluded that the SF-36 could be used in measuring outcome in the 
surgical treatment of CSM. 
3.10 Patient perceived outcome and CSM
In  a  prospective  study on  208  patients  undergoing  CC  for  CSM  (33),  the  patients’ 
perception of the outcome of surgery was studied considering the possibility that it might 
add another dimension to outcome assessment not reflected by other outcome measures. 
There were patients in both, the good Nurick grade group (preoperative grade 1-3) and in 
the poor Nurick grade group (preoperative grade 4 or 5), who reported improvement but 
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did not change their Nurick grade after surgery. The mean PPOS of such patients ranged 
from 30 to 90 (mean, 65; median, 70) in the good Nurick grade group and from 20 to 50 
(mean, 39.4; median, 40) in the poor Nurick grade group. 
A positive correlation was obtained between the patient perceived outcome score (PPOS) 
and the Nurick grade recovery rate (defined below). In most patients, PPOS paralleled 
change in Nurick grade, but in some, especially in the good grade patients, the PPOS 
seemed to indicate a better outcome from surgery than the Nurick grade. This suggested 
that the 2 scales evaluate slightly dissimilar functional domains in these patients.
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4.    PATIENTS AND METHODS
During the period commencing July 2003 to April 2007, seventy patients with cervical 
spondylotic myelopathy  presenting in Neurosurgery unit II were prospectively studied. 
All patients had unequivocal evidence of cervical cord compression due to spondylotic 
disease. After informed consent was obtained, a structured interview was used to collect 
information  on  demographic  characteristics,  co-morbid  diseases  and  CSM symptoms. 
Details of a standardized neurological examination were noted.
All patients underwent uninstrumented central corpectomy, fusion with iliac or fibular 
bone graft and immobilization with a Philadelphia collar for six months postoperatively. 
The patients were followed up 12 months later, either by correspondence or on a repeat 
visit.   
The patients’ health status was assessed preoperatively and at one year follow-up using 
the Nurick grade, the SF-36 and WHOQOL-BREF questionnaires.  At follow-up, the 
patients’ self -perceived percentage improvement in health status was also obtained. 
4.1   Classification by Nurick grades
Patients were divided into 2 groups according to their Nurick scores. Patients with Nurick 
grades from 1 to 3 were classified as “Good”, while those with scores of 4 or 5   were 
classified as “Poor.” The results of the two groups were analysed separately for all 
aspects of this study. 
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The change in Nurick grade was computed as a recovery rate percentage using the 
following formula: 
Nurick grade recovery rate (NGRR) = preoperative Nurick grade – follow-up Nurick 
grade / preoperative Nurick grade x 100. For example, a patient with a preoperative 
Nurick grade of 3 who improved to Nurick 2 after surgery would have an NGRR of 33%. 
This was used as an index of improvement in mobility and was used for analysis as a 
continuous variable.
4.2   Regional Language Translations
For the purpose of this study,  the English versions of the SF-36 were translated into 
Hindi, Bengali and Tamil to facilitate responses from the respective lingual groups. These 
translated versions were back-translated into English and then compared with the original 
English version. Changes as necessary were made in the text. 
The official versions of English, Hindi, and Tamil languages of WHOQOL-BREF were 
used for this study.  The English version was translated into Bengali and this translated 
version  was  also  back-translated  into  English  and  then  compared  with  the  original 
English version. Changes as necessary were made in the text. 
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4.3   Sample size
The formula used for determining a suitable sample size was:
n= 4 p q /d2 
Using:
p=65  from a  previous  study  (22)  in  which  64% of  the  patients  in  the  study group 
improved following surgery, 
q= 100-p=100-65=35,
d=15, 
then n=40.
The total number of patients recruited in the study was 70. 
4.4   Normative Data
The  SF-36  and  WHOQOL-BREF  scores  of  the  study  group  were  compared  with 
normative  data  from  an  age-matched  population  from  similar  regional  and  cultural 
backgrounds. 
4.5   Scoring the SF-36
 Figure 4-1 shows the structure of SF-36 scoring system. It consists of 36 questions, 35 of 
which are compressed into eight multi-item scales. Question 2, self-evaluation of change 
in health during the past year (reported health), does not belong to any score, dimension, 
or the total SF36 score. The eight scales are:
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a) Physical functioning is a ten-question scale that captures abilities to deal with the physical requirement 
of life, such as attending to personal needs, walking, and flexibility;
b)  role-physical is a four-item scale that evaluates the extent to which physical capabilities limit activity; 
c) Bodily pain is a two-item scale that evaluates the perceived amount of pain experienced during the 
previous 4 weeks and the extent to which that pain interfered with normal work activities; 
d) General health is a five-item scale that evaluates general health in terms of personal perception; 
e) Vitality is a four-item scale that evaluates feelings of pep, energy, and fatigue; 
It is to be noted that vitality and general health scales are overlapping components of both the physical 
health and mental health dimensions.
f) Social functioning (SF) is a two-item scale that evaluates the extent and amount of time, if any, that 
physical health or emotional problems interfered with family, friends, and other social interactions 
during the previous 4 weeks; 
g) Role-emotional (RE) is a three-item scale that evaluates the extent, if any, to which emotional factors 
interfere with work or other activities; and 
h) Mental health is a five-item scale that evaluates feelings principally of anxiety and depression. 
Hence, in the SF36 scoring system, the scales are assessed quantitatively, each on the basis of answers to 
two to ten multiple choice questions, and a score between 0 and 100 is then calculated on the basis of well-
defined guidelines, with a higher score indicating a better state of health (28). 
An Excel program was used for calculating the SF-36 scores (14). 
“Improvement” in the SF-36 score was defined as improvement of 5 or more (out of 100) in the individual 
scale score or the total score.
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Figure 4-1. The SF-36 quality of life (QOL) scoring system and its scales and 
dimensions.
4.6   Scoring the WHOQOL-BREF (40)
The WHOQOL-BREF produces  a  quality of life  profile.  It  is  possible  to  derive four 
domain scores. There are also two items that are examined separately: question 1 asks 
about an individual’s overall perception of quality of life and question 2 asks about an 
individual’s  overall  perception  of  their  health.  The  four  domain  scores  denote  an 
individual’s perception of quality of life in each particular domain. Domain scores are 
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scaled in a positive direction (i.e. higher scores denote higher quality of life). The mean 
score of items within each domain is used to calculate the domain score. Mean scores are 
then multiplied by 4 in order to make domain scores comparable with the scores used in 
the WHOQOL-100. A method for the manual calculation of individual scores is given in 
Figure 4-2. The method for converting raw scores to transformed scores when using this 
method is given in Appendix D 
Figure 4-2. Method for the manual calculation of individual domain scores
An SPSS syntax file that automatically checks, recodes data and computes 
domain scores  developed by  from Professor Mick Power, Department of 
Psychiatry, Royal Edinburgh Hospital, Morningside was used for calculations. 
“Improvement” in the WHOQOL-BREF score was defined as improvement of 5 or more 
(out of 100) in the individual domains and 20 or more (out of 400) in the total score. 
4.7 Patient perceived outcome score (PPOS)     
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Patients were asked to report their perception of the outcome of surgery as a 
percentage (0-100) relative to their  preoperative status. Patients who felt  that 
there was no change in their health status reported a score of 0, and those who 
became asymptomatic after surgery reported a score of 100.
4.8   Statistical Methods
The Pearson's correlation is used to find a correlation between at least two continuous 
variables.  The  value  for  a  Pearson's  can  fall  between 0.00  (no  correlation)  and 1.00 
(perfect  correlation).  Generally,  correlations  between  0.40  and  0.60  are  considered 
moderate, while those above 0.60 are considered high. In our analysis, this tool was used 
for establishing correlations between the different outcome measures and that between 
the various subscales and domains of the QOL instruments.
The Mann-Whitney U is one of the best-known non-parametric significance tests and is used for assessing 
whether two independent samples of ordinal or continuous observations come from the same distribution. 
The  null hypothesis is that the two samples are drawn from a single population, and therefore that their 
probability distributions are equal.  In  this  study,  this tool  was used for  checking correlations between 
symptoms/signs and QOL scores.
Wilcoxon  Signed-Rank  Test  is  a nonparametric  procedure  used  with  two  related 
variables to test the hypothesis that the two variables have the same distribution. It  
makes no assumptions about the shapes of the distributions of the two variables. This  
test takes into account information about the magnitude of differences within pairs  
and gives more weight to pairs that show large differences than to pairs that show 
small differences. In our analysis, this test was used to check whether the change in 
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QOL scores at follow-up in the two Nurick groups was significant. 
Kappa can be used as a measure of agreement between model predictions and 
reality (Congalton1991) or to determine if the values contained in an error matrix 
represent a result significantly better than random (Jensen 1996).  Cohen's kappa 
measures the agreement between the evaluations of two raters when both are rating the 
same  object.  A  value  of  1  indicates  perfect  agreement.  A  value  of  0  indicates  that 
agreement is no better  than chance.  Kappa is only available for tables in which both 
variables  use the  same category values  and both variables  have  the  same number  of 
categories. This procedure is a useful way to evaluate the performance of classification 
schemes  in  which  there  is  one  variable  with  two  categories  by  which  subjects  are 
classified.
This qualitative statistical technique has been used in this study to measure degree of 
agreement  between  improvement  in  Nurick  grade  and  improvement  in  the  QOL 
instrument scores.
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5. RESULTS
5.1 Demographics and clinical features  : 
 5.1.1   Age distribution
 
The mean age of the seventy patients in this study was 51.9 years +/- 9.9 (range, 32 – 71). 
Analysis of the data indicated that there was no correlation between age and QOL scores 
(SF-36 and WHOQOL-BREF) in either group (good or poor Nurick grades).
Pearson’s correlation with preoperative SF-36 scores was -0.104 (p=0.391) and with 
preoperative WHOQOL-BREF was -0.238 (p=0.047).
  
5.1.2 Comorbidities
Number of patients showing various comorbidities is shown below in Table 5-1:
Comorbidities No. of patients Percentage of cohort
Hypertension 17 24.3
Diabetes 12 17.1
Ischemic heart disease 2 2.9
Asthma 1 2.9
Others (lumbar canal stenosis, 
hypothyroidism)
3 4.3
Table 5-1 Distribution of comorbidities
23 (32.8%) patients had 1 or more comorbidities. There was no correlation between 
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comorbidities and QOL scores (SF-36 and WHOQOL-BREF) in either group.
5.1.3   Symptoms And Signs
The number of patients with various symptoms and signs at presentation is shown below 
in Table 5-2:
Symptoms Number of patients Percentage of cohort
Numb hands/arms 67 95.7
Numb legs/feet 64 91.4
Clumsy hands 56 80
Neck pain 31 44.3
Difficulty in climbing 49 70
Difficulty in eating 38 54.3
Walking aid 22 31.4
Signs Number of patients Percentage of cohort
Hyperreflexia 68 97.1
Hand intrinsic muscle 
atrophy 56 80
Hand intrinsic muscle 
weakness 48 68
Hoffmann sign 56 80
Ankle clonus 24 34
Babinski sign 61 87
Table 5-2 Patients’ symptoms and signs.
We used the Mann-Wilcoxon (MWW) non-parametric test for independent samples 
(symptoms or signs and QOL scores) and found that there was significant correlation 
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only between:
a) Numb legs /feet and total SF-36 scores (p=0.045)
b) Difficulty in climbing and total SF-36 scores (p=0.013)
c) Difficulty in eating and total SF-36 scores (p=0.006)
d) Use of  walking aid and total SF-36 scores (p=0.045)
e) Hoffmann’s sign and total SF-36 scores (p=0.001 
5.2 Preoperative scores 
 5.2.1   SF-36 
 Figures 5-3 to 5-13 below show the distribution and mean Preoperative scores of the   
 eight components of SF-36, as well as for the Physical Component summary (PCS), 
 the Mental Component summary (MCS) and the Total SF-36 scores.
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Phy sical Component Summary  
85
65
45
25
5
N
o.
 o
f p
at
ie
nt
s
12
10
8
6
4
2
0
Std. Dev = 18.03  
Mean = 34
N = 70.00
Mental Component Summary
908070605040302010
N
o.
 o
f p
at
ie
nt
s
20
10
0
Std. Dev = 19.54  
Mean = 39
N = 70.00
                             
SF-36 Total score 
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
N
o
. 
o
f 
p
a
tie
n
ts
14
12
10
8
6
4
2
0
Std. Dev = 18.42  
Mean = 35
N = 70.00
   5.2.2 WHOQOL-BREF
   Figures 5-14 to 5-18 below show the distribution and mean preoperative scores of the  
   four domains of WHOQOL-BREF, as well as for the total score.
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   5.2.3 Nurick grade
Out of the 70 patients included in this study, 47 (67%) were classified as “Good” Nurick 
grade (1- 3); and the remaining 23 patients were classified as “Poor” Nurick grade (4 or 
5).    
The mean Nurick grade for the whole group of 70 patients was 3.10, while that for the 
good group was 2.60 and that for poor group was 4.22. 
The distribution and mean of Nurick grade for the whole group is represented in the 
histogram in Fig. 5-19.
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Fig. 5-18
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5.3 Comparison of preoperative scores of study group with normative  
      scores
  SF-36: 
  Analysis by T-test of significance showed that the mean total SF-36 score for the  
  normative population was 67.92 +/- 19.05 as compared to 35.01 +/- 18.43 for  
  the study group, and this difference was significant (p<0.001).
   WHOQOL-BREF:
   Analysis by T-test of significance showed that the mean total WHOQOL-BREF   
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   score for the normative population was 262.64 +/- 44.33 as compared to 203.81 +/-    
   52.28 for the study group, and this difference was significant (p<0.001).
 5.4 Comparison of preoperative scores with follow-up scores
    5.4.1 SF-36
     Analysis was done using the Wilcoxon Signed Ranks Test 
Whole cohort: 
For all scales, there was a significant improvement in the follow-up scores (p<0.05) 
      The error bar charts shown in Figures 5-20 to 5-30 below reflect improvement  
      (preoperative to follow-up) of the mean scores of the eight components of SF-36, as  
       well as for the Physical Component summary (PCS), the Mental Component 
       summary (MCS) and the Total SF-36 scores for the whole cohort.
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 For the good Nurick group:
 For all scales, there was a significant improvement in the follow-up scores (p<0.05)
 For the poor Nurick group: 
       Except for Role Physical and general health, for all other scales, there was a   
       significant improvement in the follow-up scores (p<0.05)
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5.4.2 WHOQOL-BREF
       Analysis was done using the Wilcoxon Signed Ranks Test 
 
       Whole cohort
       For all domains except domain 3 (social relations), there was a significant 
       improvement in the follow-up scores (p<0.05)
 
 The simple error bar charts shown in Figures 5-31 to 5-35 below reflect the   
 improvement (preoperative to follow-up) of the mean scores of the four domains of   
 WHOQOL-BREF, as well as for the total score for the whole cohort.
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        For the good Nurick group:
        For all domains except domain 3 (social relations), there was a significant 
        improvement in the follow-up scores (p<0.05).
 
        For the poor Nurick group:
        Except for domain 3 (social relations) and 4 (environment), for the other two
        domains (physical and psychological), there was a significant improvement in the 
        follow-up scores (p<0.05).
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5.4.3 Nurick grade recovery rate (NGRR)
        While the NGRR for the whole group was 43%, that for the good group was 44% 
        and that for the poor group was 42%.
  
        The error bar charts in Figures 5-36 to 5-38 show the Nurick improvement 
        (preoperative to follow-up) in absolute terms, for the poor and the good groups and 
        for the whole group (p<0.001).
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5.5 Patient perceived outcome score (PPOS)
The PPOS was positive in 68 (97.1%) of the patients. The PPOS group ranged from 0 
to 100 (mean, 60.11; median, 60) in the good Nurick and from 20 to 90 (mean, 67.17; 
median, 70) in the poor Nurick group.    
5.6 Correlation between outcome measures - Qualitative analysis 
Kappa analysis was done to assess degree of agreement: between improvement in 
different outcome measures. 
5.6.1 Nurick grade and SF-36 
Degree of agreement between improvement (1 or more) in Nurick grade and 
improvement (5 or more) in SF-36 total scores was found to be not significant:
Whole cohort                : Kappa = 0.255
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P<0.001
Fig. 5-38
For good Nurick grade: Kappa = 0.287
For poor Nurick grade:  Kappa = 0.104
Similarly, the degree of agreement between improvement (1 or more) in Nurick grade 
and improvement (5 or more) in individual SF-36 scales as well the Component 
Summary scales (PCS and MCS) were all found to be not significant.
5.6.2   Nurick grade and WHOQOL-BREF
Degree  of  agreement  between  improvement  (1  or  more)  in  Nurick  grade and 
improvement  (20 or  more)  in  WHOQOL-BREF total  scores was  found to  be not 
significant:
Whole cohort                : Kappa = -0.029
For good Nurick grade: Kappa =   0.007
For poor Nurick grade:  Kappa = -0.155
Similarly, the degree of agreement between improvement (1 or more) in Nurick grade 
and improvement (5 or more) in individual domains of the WHOQOL-BREF were all 
found to be not significant.
The degree of agreement between patient perceived outcome score and improvement (5 
or more) in individual scales of SF-36 as well as the 4 domains of the WHOQOL-
BREF were all found to be not significant. 
5.7 Correlation between outcome measures - Quantitative analysis:
5.7.1 Correlation amongst Patient perceived outcome score, Nurick grade recovery 
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rate, SF-36 and WHOQOL-BREF  
The scatter-plot matrix showing the correlation between various instruments is shown below 
       PPOS
       NGRR
   SF-36 TSC
  WHOQOL TSC
                  
Pearson’s correlates between patient perceived outcome score, Nurick grade recovery 
rate, SF-36 Total score change and WHOQOL-BREF Total score change for the whole 
cohort are shown in Table 5-3 below.    
Correlations-Whole cohort (N=70)
PPOS NGRR SF-36 TSC WHOQOL-
BREF TSC
 PPOS Pearson 
Correlation 1   0.320 **  0.296 * -0.001
 Sig. (2-tailed)
- 0.007 0.013 0.992
 NGRR Pearson 
Correlation
  
  0.320 ** 1 0.174 -0.068
 Sig. (2-tailed) 0.007 - 0.150 0.576
 SF-36 TSC Pearson 
Correlation   0.296 * 0.174 1 0.054
 Sig. (2-tailed) 0.013 0.150 - 0.656
 WHOQOL- Pearson -0.001 -0.068 0.054 1
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PPOS                = Patient perceived   
                             outcome score 
NGRR               = Nurick grade 
                              recovery rate 
SF-36 TSC        =  SF-36 Total score  
                              change
WHOQOL TSC = WHOQOL-BREF 
                              Total score change  
Fig. 5-39 Scatter-plot matrix for correlation between instruments
BREF TSC Correlation
 Sig. (2-tailed) 0.992 0.576 0.656 -
            
            **        Correlation is significant at the 0.01 level (2-tailed).
       *         Correlation is significant at the 0.05 level (2-tailed).
Table 5-3 Correlations amongst instruments – whole cohort
From the above table, it becomes apparent that there were positive correlations between 
PPOS and NGRR (r=0.320, p=0.007), and between PPOS and SF-36 total score change 
(r=0.296,  p=0.013).  The  correlations  between  the  other  outcome  measures  were  not 
statistically significant. 
Pearson’s correlates  between patient  perceived outcome score,  Nurick grade recovery 
rate, SF-36 Total  score change and WHOQOL-BREF Total score change for the two 
Nurick groups are shown in Tables 5-4 and 5-5 below.    
Correlations-Good Nurick group (N=47)
PPOS NGRR SF-36 TSC WHOQOL-BREF 
TSC
PPOS Pearson 
Correlation
1 0.260 0.354* 0.276
Sig. (2-tailed) - 0.078 0.015 0.061
NGRR Pearson 
Correlation
0.260 1 0.320* 0.144
Sig. (2-tailed) 0.078 - .029 .335
SF-36 TSC Pearson 
Correlation
0.354* 0.320* 1 0.342*
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Sig. (2-tailed) 0.015 0.029 - 0.019
WHOQOL-
BREF TSC
Pearson 
Correlation
0.276 0.144 0.342* 1
Sig. (2-tailed) 0.061 0.335 0.019 -
* Correlation is significant at the 0.01 level (2-tailed). 
 Table 5-4 Correlations amongst instruments – good Nurick group
Correlations -Poor Nurick group (N=23)
PPOS NGRR SF-36 TSC WHOQOL-BREF 
TSC
PPOS Pearson 
Correlation
1 0.580 * 0.113 -0.535 *
Sig. (2-tailed) 0. 0.004 0.607 0.008
NGRR Pearson 
Correlation
0.580 * 1 -0.061 -0.312
Sig. (2-tailed) 0.004 0. 0.783 0.147
SF-36 TSC Pearson 
Correlation
0.113 -0.061 1 -0.254
Sig. (2-tailed) 0.607 0.783 .  0.242
WHOQOL-
BREF TSC
Pearson 
Correlation
-0.535 * -0.312 -0.254 1
Sig. (2-tailed) 0.008 0.147 0.242 .
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* Correlation is significant at the 0.01 level (2-tailed).
  
Table 5-5 Correlations amongst instruments – poor Nurick group
For the good Nurick group (Table 5-4), positive correlations were obtained between 
PPOS and SF-36 total score change (r=0.354, p=0.015) and between NGRR and SF-36 
total score change(r =0.320, p=0.029). 
 For the poor Nurick group (Table 5-5), a positive correlation was obtained between 
PPOS and NGRR (r=0.580, p=0.004).  A negative correlation was obtained between 
PPOS and WHOQOL-BREF total score change (r=-0.535, p=0.008)..
5.7.2 Correlation between SF-36 and WHOQOL-BREF
Reliability for the SF-36 subscales and WHOQOL-BREF domains is high for the study 
samples (alpha =0.9032 and 0.7447 respectively). Pearson’s correlation coefficients 
between SF-36 scales and WHOQOL-BREF domains are shown in Table 5-6.
SF-36
PF RP BP GH VT SF RE MH Dom 2
Dom 
2
Dom 
3
Dom 
4
PF 1
RP 0.254a
0.034b
1
BP 0.546
0.000
0.297
0.012
1
GH 0.133
0.272
0.126
0.299
0.307
0.010
1
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VT 0.422
0.000
0.438
0.000
0.532
0.000
0.344
0.004
1
SF 0.434
0.000
0.273
0.022
0.428
0.000
0.290
0.015
0.683
0.000
1
RE 0.100
0.410
0.604
0.000
0.262
0.028
0.111
0.362
0.454
0.000
0.292
0.014
1
MH 0.266
0.026
0.256
0.033
0.396
0.001
0.261
0.029
0.662
0.000
0.389
0.001
0.534
0.000
1
WHOQOL-BREF
Dom 
   1
0.577
0.000
0.229
0.056
0.535
0.000
0.268
0.025
0.398
0.001
0.415
0.000
0.131
0.278
0.170
0.159
1
Dom 
    2
0.392
0.001
0.150
0.217
0.315
0.008
0.236
0.050
0.324
0.006
0.220
0.067
0.040
0.744
0.347
0.003
0.457
0.000
1
Dom  
    3
0.233
0.053
0.151
0.211
0.205
0.088
0.370
0.002
0.215
0.074
0.313
0.008
-0.005
0.969
0.121
0.319
0.372
0.002
0.477
0.000
1
Dom  
   4
0.064
0.598
-0.114
 0.346
0.028
0.816
0.287
0.016
0.036
0.766
-0.003
0.982
-0.151
0.211
0.116
0.339
0.230
0.056
0.560
0.000
0.495
0.000
1
a = Pearson’s correlate (r)
b = Significance (p)
Table 5-6 Correlation coefficients between SF-36 and WHOQOL-BREF scales and domains
PF (physical functioning), BP (bodily pain) and SF (social functioning) were moderately 
correlated (r > 0.40) with domain 1 (Physical domain) of WHOQOL-BREF. 
The other subscales of SF-36 correlated weakly (r < 0.4) with any of the domains of the 
WHOQOL-BREF. 
Analysing intra-class correlations, the domains of the WHOQOL-BREF were moderately 
correlated (r: 0.4-0.6) with each other, as were some of the scales of the SF-36. 
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6.    DISCUSSION
The  entire  study population  with  CSM  was  found  to  have  a  significantly  decreased 
quality of life (measured by SF-36 and WHOQOL-BREF instruments) as compared with 
age-matched normative population from similar cultural and regional backgrounds. The 
scores were expectedly worse for the poor Nurick grade patients. It is to be noted that 
even the good grade patients had a significantly worse QOL compared with normative 
scores. 
6.1   Change in Nurick grade
The mean preoperative Nurick grade of the whole cohort was 3.10.  A large proportion of 
the patients had a significant ambulatory dysfunction (74.2 % were Nurick grade 3 or 
higher). This degree of functional impairment was similar to that noted in other published 
series. (2, 7). The mean Nurick grade improved significantly from 2.6 to 1.43 (p<0.001) 
in the good Nurick group and from 4.22 to 2.43 (p<0.001) in the poor Nurick group.  
33 of the 70 patients became “normal” or “cured” (defined as follow-up Nurick grade 0 
or 1). Out of these, 26 were from the good group and 7 were from the poor group.  30.4% 
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of patients in the poor group obtained a “cure”. This finding was similar to that of a 
previous  study (34)  where  24% of  the  poor  grade patients  had obtained  a  cure  after 
surgery. 
Nurick grade recovery rate (defined as preoperative minus follow-up grade divided by the 
preoperative grade x 100), was used as an index of improvement in mobility and was 
used for analysis as a continuous variable. This was almost similar for both the groups 
(44% for the good Nurick group and 42% for the poor Nurick group).  
These  results  indicate  that  there  was  no  significant  difference  in  the  degree  of 
improvement in the myelopathy scale scores between the two Nurick groups. 
6.2   Change in QOL scores in the good and poor grade groups
Most of the published series on outcome analysis in patients with CSM have reported 
results in patient with better Nurick grades (grade 1-3). The reported functional outcome 
in patients with worse Nurick grades has been varied. In the first report (34) published 
exclusively on outcome in patients with poor Nurick grade after decompressive surgery, 
it was observed that more than three-fourth such patients improved in their functional 
status. The observed change in the SF-36 and WHOQOL-BREF scores in the two Nurick 
groups is discussed below.
a) Change in SF-36 Scores
In our study, it was found that there was a significant change in scores at follow-up in all 
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scales for the whole cohort, and for the good Nurick grade group. In the poor Nurick 
grade  group,  the  “role  physical”  and  “general  health”  scale  scores  did  not  improve 
significantly.  
The  “role  physical”  subscale  objectively  (yes/no  answers)  covers  difficulties  in 
accomplishing  routine  physical  activities.  The  poor  Nurick  grade  patients,  inspite  of 
improving substantially as assessed by other measures, probably did not feel adequately 
healthier to demonstrate improvement in this very objective subscale. 
“General  health”  includes  questions  derived  from items  assessing  the  patient’s  self-
perceived general health rating as compared to normal people. Though the poor grade 
patients did not improve significantly in this rating, this should not be construed as lack 
of self-perceived improvement. The poor grade patients in fact reported a higher mean 
self-reported improvement value at 67.17 % (S.D. 15.65) as compared to 60.11 % (S.D. 
23.75) reported by  the good grade patients.
Interestingly, as found in a previous study conducted by King et al (15), difficulties of the 
study patients were found to extend beyond physical debility to diminished emotional 
functioning and mental health, and these improved after surgery. 
In another study by King et al (16), only the MCS had improved postoperatively in the 
patients  who reported improvement.  In this  study,  both the MCS and PCS improved 
significantly.  The  PCS for  the  whole  cohort  improved  from 34 to  52  and  the  MCS 
improved from 39 to 57. Improvement in both these component summary measures was 
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significant across all Nurick grades.
The facets  within the mental  health  summary scores include those related to anxiety, 
depression, social functioning, freedom, opportunities for acquiring new information and 
skills, and participation in leisure activities. Of these, depression and anxiety have been 
shown to be  strongly associated  with decreased  mobility  (19).  Improvement  in  these 
areas  of  functioning  probably  result  from changes  seen  commonly  in  CSM  patients 
following surgery i.e. improvement in overall mobility.
b) Change in WHOQOL-BREF  Scores
There was significant follow-up improvement in the physical and psychological scores 
for both the groups. These domains are derived from mobility and mental status related 
items respectively, and higher scores in these could be explained as above for similar 
changes in the corresponding SF-36 subscale scores. 
It was observed that social relationship was not altered significantly following surgery 
irrespective of the severity of CSM. This could be partly attributed to the socio-cultural 
prejudices prevailing in the regions where majority of the study patients hailed from viz., 
from the eastern part of the country. 
The poor grade patients did not demonstrate significant improvement in the environment 
domain  also.  The  environment  domain  includes  highly  subjective  and  self-perceived 
measures of safety, home environment, leisure, access to health care, transport and the 
60
physical environment –all important factors that contribute to the global health status of 
an individual.  The relatively poor environment conditions prevailing in the eastern part 
of the country could have had an additional impact on the disease-related burden in the 
poor  grade patients,  making the conditions  more unbearable  than for the good group 
patients.
6.3   Correlation between outcome measures
 6.3.1 Qualitative analysis 
It would be natural to expect a fairly high degree of agreement between improvement in 
the myelopathy scale and the mobility-related items of the two QOL instruments, as also 
reported in a previous study (18). However, in this study, it was found that there was no 
congruence between the Nurick grade and the preoperative PCS score of the SF-36 or 
domain 1 (physical domain) score of the WHOQOL-BREF. This reflects that these two 
outcome  measures  are  mutually  exclusive  and  hence  the  need  for  using  them  to 
supplement each other. 
6.3.2 Quantitative analysis
For the whole cohort (Table 5-3) and for the poor Nurick group (Table 5-5), there was a 
positive correlation between NGRR and PPOS. Such a correlation between the objective 
NGRR and the subjective PPOS, obtained in another study as well (33), reflects the high 
priority that patients with CSM tend to place on mobility in preference to other factors 
while considering improvement in their health status. 
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Analysing correlations between the QOL instruments and other outcome measures, the 
SF-36 total score change was positively correlated with PPOS and NGRR in the good 
group (Table 5-4). The WHOQOL-BREF had no significant positive correlation with the 
other  outcome measures in  either  of the Nurick groups.  This indicates that  while  the 
generic  SF-36  scale  and  the  PPOS  and  NGRR  may  have  measured  similar  health 
dimensions at least in some patients, the WHOQOL-BREF seems to have functioned as a 
mutually exclusive outcome measure.
6.4   Correlation between SF-36 and WHOQOL-BREF
Cronbach’s alpha was used to measure internal consistency of the two QOL instruments. 
The alpha values for the overall QOL measurement by the SF-36 and WHOQOL-BREF 
were 0.90 and 0.74 respectively (alpha > 0.7 is an acceptable co-efficient).  Convergent 
and discriminant validity of the subscales of the two instruments was measured using 
multitrait analysis (Table 5-6). 
In the study sample, of all the subscales that measure similar concepts in the SF-36 and 
WHOQOL-BREF,  only  PF  (physical  functioning),  BP  (bodily  pain)  and  SF  (social 
functioning) were moderately correlated (r > 0.40) with domain 1 (Physical domain) of 
WHOQOL-BREF.  This finding corroborates the observations made in earlier  studies 
(11). 
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The other subscales of SF-36 correlated weakly (r < 0.4) with any of the domains of the 
WHOQOL-BREF.  The domains  of  the  WHOQOL-BREF were  moderately correlated 
with each other (r: 0.4-0.6). 
For SF-36, the inter-subscale correlation was moderate for:  
- BP (bodily pain) with PF (physical functioning); 
- VT (vitality) with PF (physical functioning), RP (role physical) and BP (bodily pain);
 -SF (social functioning) with PF (physical functioning), BP (bodily pain) and VT     
   (vitality);
- RE (role emotional) with RP (role physical) and VT (vitality);
- MH (mental health) with VT (vitality) and RE (role emotional).
The  above observations  can  be  explained  by the  fact  that  the  two instruments  were 
designed  with  different  objectives  and  have  been  established  to  measure  different 
constructs (11, 10). While the objective of WHOQOL-BREF was to measure a broad 
ranging concept of QOL, that of the SF-36 was to measure health- related QOL focused 
on health related functioning and perceptions. Further more, WHOQOL-BREF measures 
subjective QOL aspects while the SF-36 measures objective capabilities and functioning.
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7. CONCLUSIONS  
1. Patients with CSM, including those with good Nurick grades (1-3), experience a 
decreased quality of life compared to normative population.
2. There was a significant improvement in scores of all the SF-36 scales at follow-
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up for the good Nurick grade group. For the poor Nurick grade group, except for 
the scores of the “role physical” and “general health” scales, there was a 
significant improvement in scores of all the other scales. 
3. There was significant improvement in the physical and psychological WHOQOL-
BREF domain scores at follow-up for patients in both the Nurick groups.  The 
scores  of  the  social  relationship  domain  in  both  the  groups,  and  that  of  the 
environment domain in the poor grade group did not improve significantly.
4. Amongst the different outcome measures used, there was an association between 
Nurick grade recovery rate (NGRR) and patient perceived outcome score (PPOS) 
in the poor Nurick group. Change in the SF-36 scores was positively correlated 
with  NGRR  and  PPOS  in  the  good  Nurick  group.  This  underscores  the 
importance of a multimodal outcome assessment in patients with CSM.
5. Since there was moderate correlation only between physical functioning, bodily 
pain  and  social  functioning  subscales  of  the  SF-36  with  domain  1  (Physical 
domain) of WHOQOL-BREF, it is recommended that both the instruments be 
used in conjunction to obtain a comprehensive assessment of quality of life for 
patients with cervical spondylotic myelopathy. 
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Appendix A
Scoring the SF-36 Questionnaire (39)
                         
All questions are scored on a scale from 0 to 100, with 100 representing the highest level 
of functioning possible. Shown below is the scoring system of the RAND 36-Item Health 
Survey 1.0 (distributed by RAND), which has the same items and similar scoring 
algorithm as that of the SF-36.  Aggregate scores are compiled as a percentage of the 
total points possible (STEP I chart). The scores from those questions that address each 
specific area of functional health status (STEP II chart) are then averaged together. 
         STEP 1: SCORING QUESTIONS:
Question Number Original Response Recorded Value
1, 2, 20, 22, 34, 36
1 100
2 75
3 50
4 25
5 0
3, 4, 5, 6, 7, 8, 9, 10, 11, 12
1 0
2 50
3 100
13, 14, 15, 16, 17, 18, 19
1 0
2 100
21, 23, 26, 27, 30
1 100
2 80
3 60
4 40
5 20
6 0
24, 25, 28, 29, 31
1 0
2 20
3 40
4 60
5 80
6 100
32, 33, 35
1 0
2 25
3 50
4 75
5 100
      STEP 2: AVERAGING ITEMS TO FORM 8 SCALES:
Scale Number Of 
Items
After Recording as per 
Table 1, Average the 
following  Items
Physical Functioning 10 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Role limitations due to physical 
health
4 13, 14, 15, 16
Role limitations due to 
emotional problems
3 17, 18, 19
Energy/ fatigue 4 23, 27, 29, 31
Emotional well being 5 24, 25, 26, 28, 30
Social functioning 2 20, 32
Pain 2 21,22
General health 5 1,33,34,35,36
 
APPENDIX B
Scoring the WHOQOL-BREF (38)
  A method for the manual calculation of individual scores is given in Fig.4-2. The 
method for converting raw scores to transformed scores when using this method is given 
in Table D-1 below. The first transformation method converts scores to range between 
4-20. The second transformation method converts domain scores to a 0-100 scale.
Where more than 20% of data is missing from a assessment, the assessment is discarded. 
Where an item is missing, the mean of other items in the domain is substituted. Where 
more than two items are missing from the domain, the domain score is not calculated 
(with the exception of domain 3, where the domain should only be calculated if less than 
1 item is missing).
Table D-1. Method for converting raw scores to transformed scores
Appendix  C                   Short Form 36 Health Survey  
Appendix D
 SF36 Health Survey. INSTRUCTIONS: This set of questions asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual activities. Answer every question by marking the answer as 
indicated. If you are unsure about to answer a question please give the best answer you can.
1. In general, would you say your health is: (Please tick one box.)
Excellent               Very Good                Good                Fair                        Poor   
2. Compared to one year ago, how would you rate your health in general now? (Please tick one box.)
Much better than one year ago                      
Somewhat better now than one year ago 
About the same as one year ago               
Somewhat worse now than one year ago 
Much worse now than one year ago         
3. The following questions are about activities you might do during a typical day. Does your health now limit you in these 
activities? If so, how much? (Please circle one number on each line.)
  Activities Yes, 
Limited 
A Lot
Yes, Limited 
A Little
Not Limited  at 
All
3(i) Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports
1 2 3
3(ii) Moderate activities, such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf
1 2 3
3(iii) Lifting or carrying groceries 1 2 3
3(iv) Climbing several flights of stairs 1 2 3
3(v) Climbing one flight of stairs 1 2 3
3(vi) Bending, kneeling, or stooping 1 2 3
3(vii) Waling more than a mile 1 2 3
3(viii) Walking several blocks 1 2 3
3(ix) Walking one block 1 2 3
3(x) Bathing or dressing yourself 1 2 3
4. During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a 
result of your physical health? (Please circle one number on each line.)
  YES NO
4(i ) Cut down on the amount of time you spent on work or other activities 1 2
4(ii ) Accomplished less than you would like 1 2
4(iii) Were limited in the kind of work or other activities 1 2
4(iv) Had difficulty performing the work or other activities (for example, it took extra 
effort)
1 2
5. During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or anxious)?
 (Please circle one number on each line.) Yes No
5(i) Cut down on the amount of time you spent on work or other activities 1 2
5(ii) Accomplished less than you would like 1 2
5(iii) Didn’t do work or other activities as carefully as usual 1 2
6. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social 
activities with family, friends, neighbours, or groups? (Please tick one box.)
Not at all       Slightly      Moderately          Quite a bit              Extremely  
7. How much physical pain have you had during the past 4 weeks  ? (Please tick one box.)
None      Very mild      Mild       Moderate        Severe         Very Severe   
8. During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and 
housework)? (Please tick one box.)
Not at all       A little bit        Moderately       Quite a bit          Extremely 
9. These questions are about how you feel and how things have been with you during the past 4 weeks. Please give the 
one answer that is closest to the way you have been feeling for each item.
 (Please circle one number on each 
line.)
All of the 
Time
Most 
of the 
Time
A Good 
Bit of the 
Time
Some of 
the 
Time
A Little 
of the 
Time
None of the 
Time
9(i) Did you feel full of life? 1 2 3 4 5 6
9(ii) Have you been a very nervous person? 1 2 3 4 5 6
9(iii) Have you felt so down in the dumps that 
nothing could cheer you up?
1 2 3 4 5 6
9(iv) Have you felt calm and peaceful? 1 2 3 4 5 6
9(v) Did you have a lot of energy? 1 2 3 4 5 6
9(vi) Have you felt downhearted and blue? 1 2 3 4 5 6
9(vii) Did you feel worn out? 1 2 3 4 5 6
9(viii) Have you been a happy person? 1 2 3 4 5 6
9(ix) Did you feel tired? 1 2 3 4 5 6
10. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your 
social activities (like visiting with friends, relatives etc.) (Please tick one box.)
All of the time                  Most of the time            Some of the time          
A little of the time          None of the time      
11. How TRUE or FALSE is each of the following statements for you?
 (Please circle one number on each 
line.)
Definitely 
True
Mostly 
True
Don’t 
Know
Mostly 
False
Definitely False
11(i) I seem to get sick a little easier than 
other people
1 2 3 4 5
11(ii) I am as healthy as anybody I know 1 2 3 4 5
11(iii) I expect my health to get worse 1 2 3 4 5
11(iv) My health is excellent 1 2 3 4 5
  
APPENDIX  D
QUESTIONNAIRE FOR WHOQOL-BREF (38)
Please read each question, assess your feelings, and circle the number on 
the scale for each question that gives the best answer for you.
 
  
  Poor
Neither poor
Nor good
Very goodGoodVery poor


